NDC 31722-505

Nevirapine

Nevirapine

Nevirapine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is Nevirapine.

Product ID31722-505_8e6a89e9-79ce-4533-bfe4-8c53bb7ec12f
NDC31722-505
Product TypeHuman Prescription Drug
Proprietary NameNevirapine
Generic NameNevirapine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2012-05-23
Marketing CategoryANDA / ANDA
Application NumberANDA078584
Labeler NameCamber Pharmaceuticals, Inc.
Substance NameNEVIRAPINE
Active Ingredient Strength200 mg/1
Pharm ClassesHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 31722-505-01

100 TABLET in 1 BOTTLE (31722-505-01)
Marketing Start Date2012-05-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 31722-505-05 [31722050505]

Nevirapine TABLET
Marketing CategoryANDA
Application NumberANDA078584
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-05-23

NDC 31722-505-10 [31722050510]

Nevirapine TABLET
Marketing CategoryANDA
Application NumberANDA078584
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-05-23

NDC 31722-505-01 [31722050501]

Nevirapine TABLET
Marketing CategoryANDA
Application NumberANDA078584
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-05-23

NDC 31722-505-60 [31722050560]

Nevirapine TABLET
Marketing CategoryANDA
Application NumberANDA078584
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-05-23

Drug Details

Active Ingredients

IngredientStrength
NEVIRAPINE200 mg/1

OpenFDA Data

SPL SET ID:61409678-d2f6-42cd-b03d-b26b11b39641
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 199422

    • Pharmacological Class

    • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Non-Nucleoside Analog [EXT]
    • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Cytochrome P450 3A Inducers [MoA]
    • Cytochrome P450 2B6 Inducers [MoA]

    Medicade Reported Pricing

    31722050560 NEVIRAPINE 200 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Nevirapine" or generic name "Nevirapine"

    NDCBrand NameGeneric Name
    0378-4050Nevirapinenevirapine
    0378-4890Nevirapinenevirapine
    0378-6950Nevirapinenevirapine
    0781-5893NevirapineNevirapine
    31722-505NevirapineNevirapine
    33342-004NevirapineNevirapine
    33342-238NEVIRAPINENEVIRAPINE
    42571-131NEVIRAPINENEVIRAPINE
    51991-331NevirapineNEVIRAPINE
    53104-0166nevirapinenevirapine
    53808-0680Nevirapinenevirapine
    53808-1069nevirapinenevirapine
    61442-470NevirapineNevirapine
    64380-709NevirapineNevirapine
    65162-209NevirapineNevirapine
    69097-403NEVIRAPINENEVIRAPINE
    69097-233nevirapinenevirapine
    65862-057NevirapineNevirapine
    65862-027NevirapineNevirapine
    65862-932NEVIRAPINENEVIRAPINE
    65862-933NEVIRAPINENEVIRAPINE
    47781-317Nevirapine Extended Releasenevirapine
    0597-0046Viramunenevirapine
    0597-0047Viramunenevirapine
    0597-0123Viramunenevirapine
    53808-0808Viramunenevirapine
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.